The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response. uri icon

authors

  • Oom, Aaron L
  • Zucker, Jane R
  • Rosen, Jennifer B
  • Herati, Ramin Sedaghat
  • Samanovic, Marie I
  • Duerr, Ralf
  • Kottkamp, Angelica C
  • Mulligan, Mark J
  • Wilson, Kesi K
  • Yonatan, Miilani
  • Rettig, Stephanie
  • Youn, Heekoung Allison
  • Tuen, Michael
  • Shah, Yusra
  • DuMont, Ashley L
  • Hayley Belli, PhD

publication date

  • March 31, 2025